阳光诺和：拟购买朗研生命100%股权 股票交易未出现异常波动情形

Core Viewpoint - Beijing Sunshine Nuohua Pharmaceutical Research Co., Ltd. plans to acquire 100% equity of Jiangsu Langyan Life Science Technology Holdings Co., Ltd. through the issuance of shares and convertible bonds, while also raising matching funds from no more than 35 specific investors [1] Summary by Relevant Sections - Transaction Details - The company intends to purchase 100% equity of Jiangsu Langyan Life Science Technology Holdings Co., Ltd. through a combination of share issuance and convertible bonds [1] - The company will also issue shares to raise matching funds from up to 35 specific investors [1] - Stock Performance - In the 20 trading days prior to the announcement of this transaction, the company's stock price increased by 9.82% [1] - Excluding the impact of market and industry factors, the stock price fluctuation did not exceed 20% during the same period, which is below the threshold set by the Shanghai Stock Exchange for significant asset restructuring [1] - There were no abnormal fluctuations in the company's stock trading prior to the announcement of the transaction [1]